Description

What do you know about Quviviq?

Quviviq vs Ambien is a medication prescribed for the treatment of insomnia in adults. It was developed by Idorsia Pharmaceuticals and approved by the U.S. Food and Drug Administration (FDA) in 2022. It belongs to a class of drugs called orexin receptor antagonists, which work by blocking the action of orexin, a neuropeptide that promotes wakefulness. By inhibiting orexin signaling, It helps to regulate the sleep-wake cycle, allowing users to fall asleep and stay asleep more easily.

Key Details:

Indication: Treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance.
Dosage: Typically available in 25 mg and 50 mg tablets. The dose depends on individual patient needs and physician recommendations.
Mechanism of Action: It blocks orexin receptors (OX1R and OX2R) in the brain, reducing the alerting signals and promoting sleep.
Common Side Effects: Drowsiness, fatigue, and headache. It may also cause next-day drowsiness, so patients are advised to avoid driving or engaging in hazardous activities the day after taking the medication if they feel impaired.

Unlike older sleep aids, which target GABA receptors or act as sedatives, its mechanism of action aims to directly modulate the sleep-wake system. It’s seen as an alternative to other sleep medications like Ambien (zolpidem), Lunesta (eszopiclone), and other orexin antagonists like Belsomra (suvorexant).

Benefits:

1. Improves Sleep Onset and Sleep Maintenance

Quviviq vs Ambien helps both with falling asleep faster and with staying asleep throughout the night. Many sleep medications focus on either one of these aspects, but it targets both.

2. Targeted Action on Orexin

It blocks orexin, a neuropeptide responsible for wakefulness, instead of acting as a sedative. This allows for a more natural sleep cycle, without heavily depressing the central nervous system, unlike older sleep medications (like benzodiazepines or non-benzodiazepine hypnotics).

3. Lower Risk of Next-Day Drowsiness

Studies show that it has less impact on next-day functioning compared to some other sleep medications. Patients are less likely to experience excessive next-day sedation, which can interfere with daily activities like driving or work.

4. Minimal Impact on Memory and Cognition

Compared to older sedative-hypnotics, it has a lower risk of cognitive impairment or memory problems. This can be particularly beneficial for older adults or those concerned about the cognitive effects of sleep medications.

5. Not Habit-Forming

it is not classified as a controlled substance, meaning it has a lower potential for abuse or dependence compared to traditional insomnia medications like benzodiazepines or certain non-benzodiazepine sleep aids (e.g., Ambien, Lunesta).

6. Consistent Sleep Architecture

It preserves sleep architecture, meaning it does not significantly alter the stages of sleep (such as REM or deep sleep). This helps users maintain a more natural, restful sleep experience.

7. Well-Tolerated

Quviviq has a generally good safety profile and is well tolerated by most users. Common side effects like headache, drowsiness, or fatigue tend to be mild. It has a lower risk of causing serious side effects like sleepwalking or sleep-related behaviors, which have been associated with certain other sleep medications.

8. No Rebound Insomnia

Quviviq is associated with no or minimal rebound insomnia after discontinuation. This is a notable benefit, as many traditional sleep medications can cause a worsening of sleep issues once stopped.

Additional information

Bottles of Tablets	50 Tablets, 60 Tablets, 70 Tablets, 80 Tablets

Reviews

There are no reviews yet.

Be the first to review “Quviviq”

PHONE

View Cart